Together, the KIF15/PHGDH mediated imbalance of ROS homeostasis was essential to the induction of stem cell property and malignancy, targeting KIF15 could be a promising therapeutic strategy for HCC [104]. This evidence concerns the gene KIF15 and hepatocellular carcinoma.